Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas

World Journal of Gastroenterology

Volumn 6, Issue 5, 2000, Pages 664-670

  Yin, F ^a   Shi, Y Q ^a   Zhao, W P ^a   Xiao, B ^a   Miao, J Y ^a   Fan, D M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; FAS ANTIGEN; FLUOROURACIL; GLYCOPROTEIN P; MITOMYCIN C; TENIPOSIDE; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; DRUG SENSITIZATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MULTIDRUG RESISTANCE; STOMACH CANCER;

EID: 0033789685     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i5.664     Document Type: Article

References (51)

1. Tumor cell survival and resistance to therapy
2. An adherent cell model to study different stages of apoptosis
3. Apoptosis control by death and decoy receptors
4. Mechanisms and genes of cellular suicide
5. Programmed cell death in animal development
6. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
7. Apoptosis by death factor
8. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
9. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis
10. Oncogenes and cell death
11. Apoptosis and expression of bcl-2 gene in gallbladder neoplasms
12. Expression and significance of apoptosis related gene bcl-2, bax in human large intestine adenocarcinoma
13. Bcl-2, P53 protein expression and apoptosis in pancreatic cancer
14. Tumor suppressor genes
15. The genetic regulation of apoptosis
16. Mediation of c-myc-induced apoptosis by p53
17. Bcl-2 and the regulation of programmed cell death
18. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability
19. Expression of c-myc and p53 in colorectal adenoma and adenocarcinoma
20. bcl-2 and p53 expressions in colorectal adenoma and carcinoma
21. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China
22. Expression of bcl-2 protein in gastric carcinoma and its significance
23. Retrovirus-mediated antisense RNA to bcl-2 alter the biological behavior of stomach carcinoma MGC-803 cell lines
24. Expression and significance of proapoptotic gene Bax in gastric carcinoma
25. Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1, 25 (OH) 2 Vitamin D3, and granulocyte-macrophage colony-stimulating factor
26. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line
27. Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs
28. Construction of eukaryotic expression vector pBK-fas and MDR reversal test of drug-resistant gastric cancer cells
29. BAX expression is associated with enhanced intracellular accumulation of paclitaxel: A novel role for BAX during chemotherapy-induced cell death
30. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA
31. The chemoresistance of human malignant melanoma: An update
32. Induction of apoptosis in human gastric carcinoma cell line SGC-7901 by anti-Fas monoclonal antibody
33. Clinical significance of Fas antigen expression in gastric carcinoma
34. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells
35. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
36. Monoclonal antibody-mediated tumor regression by induction of apoptosis
37. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
38. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
39. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
40. FADD, a novel death domain-containing protein, interacts with death domain of Fas and initiates apoptosis
41. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
42. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/ APO-1) independently of its ligand CD95L
43. FLICE is activated by association with the CD95 Death-inducing Signaling Complex (DISC)
44. Human ICE/ CED-3 protease nomenclature
45. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death
46. FLICE, a novel FADD-homologous ICE/ CED-3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
47. FLICE induced apoptosis in a cell-free system
48. Expression significance of mdr1 gene in gastric carcinoma tissue
49. Expression of mdrl gene coded P-glycoprotein in hepatocellular carcinoma and its clinical significance
50. Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication
51. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis